Brief: Cybin Acquires Dmt Clinical Study From Entheon Biomedical
07/06/2022 14:02
June 7 (Reuters) - Cybin Inc CYBN.NLB :
* CYBIN ACQUIRES DMT CLINICAL STUDY FROM ENTHEON BIOMEDICAL
* CYBIN INC- PURCHASE PRICE OF ACQUISITION IS $1,000,000
(CAD)
Source text for Eikon: ID:nBw20D4Bma
Further company coverage: CYBN.NLB
((Reuters.Briefs@thomsonreuters.com;))